Evidence map›Paper›PMID 30366383›Full record

ArticleInternational journal of molecular sciences2018

Quercitrin Nanocoated Implant Surfaces Reduce Osteoclast Activity In Vitro and In Vivo.

Alba Córdoba, Nahuel Manzanaro-Moreno, Carme Colom, Hans J Rønold, Staale P Lyngstadaas, Marta Monjo, Joana M Ramis

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Quercitrin Is a Novel Inhibitor ofMolecules (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Emerging nanomaterials for dental treatments.Emerging topics in life sciences · 2020
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Alba CórdobaGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS), University of the Balearic Islands. Ctra. Valldemossa km 7.5, 07122 Palma de Mallorca, Spain. alba.cordoba@uib.es.
Nahuel Manzanaro-MorenoGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS), University of the Balearic Islands. Ctra. Valldemossa km 7.5, 07122 Palma de Mallorca, Spain. nauel.manzanero@gmail.com.
Carme ColomGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS), University of the Balearic Islands. Ctra. Valldemossa km 7.5, 07122 Palma de Mallorca, Spain. mcarmecolom@gmail.com.
Hans J RønoldOral Research Laboratory and Department for Prosthetic Dentistry, Institute for Clinical Dentistry, University of Oslo, P.O. Box 1109 Oslo, Norway. h.j.ronold@odont.uio.no.
Staale P LyngstadaasDepartment of Biomaterials, Institute for Clinical Dentistry, University of Oslo, P.O. Box 1109 Oslo, Norway. spl@odont.uio.no.
Marta MonjoGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS), University of the Balearic Islands. Ctra. Valldemossa km 7.5, 07122 Palma de Mallorca, Spain. marta.monjo@uib.es.ORCID 0000-0002-2731-9527
Joana M RamisGroup of Cell Therapy and Tissue Engineering, Research Institute on Health Sciences (IUNICS), University of the Balearic Islands. Ctra. Valldemossa km 7.5, 07122 Palma de Mallorca, Spain. joana.ramis@uib.es.ORCID 0000-0001-9109-8362
Health Research Institute of the Balearic Islands · ESResearch Institute of Health Sciences · ESUniversity of Oslo · NO

Funding

Conselleria d'Educació, Cultura i Universitats del Govern de les Illes Balears and the European Social Fund PD/018/2014NILS Science and Sustainability Programme ES07 EEA Grants; 013-Abel-CM-2013Osteology Foundation Grant Number: 13-069
6 · The paper itself

Abstract

In this study, the effect on osteoclast activity in vitro and in vivo of titanium implants that were coated with quercitrin was evaluated. Titanium surfaces were covalently coated with the flavonoid quercitrin. The effect of the surfaces on osteoclastogenesis was first tested in vitro on RAW264.7 cells that were supplemented with receptor activator of nuclear factor kappa-B ligand (RANKL) to generate osteoclast-like cells by tartrate-resistant acid phosphatase (TRAP) inmunostaining after five days of culture, and by analysis of the mRNA expression levels of markers related to bone resorption after seven days of culture. A rabbit tibial model was used to evaluate the in vivo biological response to the implant surfaces after eight weeks of healing, analyzing the lactate dehydrogenase (LDH) and the alkaline phosphatase (ALP) activities in the wound fluid that were present at the implant interface and the peri-implant bone mRNA expression levels of several markers related to inflammation, bone resorption and osteoblast-osteoclast interaction. No differences between groups and control surfaces were found in the wound fluid analyses. Moreover, quercitrin implant surfaces significantly decreased the expression of osteoclast related genes in vitro (

Indexed as

Prostheses and ImplantsAlkaline PhosphataseAnimalsBiocompatible MaterialsFemaleL-Lactate DehydrogenaseMiceOsseointegrationOsteoclastsOsteogenesisPolyphenolsQuercetinRabbitsRANK LigandReverse Transcriptase Polymerase Chain ReactionTartrate-Resistant Acid PhosphataseAlkaline PhosphataseBiocompatible MaterialsL-Lactate DehydrogenasePolyphenolsQuercetinquercitrinRANK LigandTartrate-Resistant Acid Phosphataseanimal experimentsbiomaterialsbone implant interactionspolyphenolssurface chemistry

Identifiers

PMID30366383
PMCPMC6274788
OpenAlexW2898483768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.